Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab.
Saved in:
| Title: | Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. |
|---|---|
| Authors: | Netea SA; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van Stijn D; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Gruppen MP; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., van den Berg JM; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Blom NA; Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kuipers IM; Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Kuijpers TW; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam, Amsterdam, The Netherlands. |
| Source: | Journal of human immunity [J Hum Immun] 2026 Apr 09; Vol. 2 (4), pp. e20250240. Date of Electronic Publication: 2026 Apr 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 9919054337406676 Publication Model: eCollection Cited Medium: Internet ISSN: 3065-8993 (Electronic) Linking ISSN: 30658993 NLM ISO Abbreviation: J Hum Immun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42169678 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Netea+SA%22">Netea SA</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Stijn+D%22">van Stijn D</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gruppen+MP%22">Gruppen MP</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Berg+JM%22">van den Berg JM</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Blom+NA%22">Blom NA</searchLink>; Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuipers+IM%22">Kuipers IM</searchLink>; Pediatric Cardiology, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kuijpers+TW%22">Kuijpers TW</searchLink>; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Department of Blood Cell Research, Sanquin Research Institute, University of Amsterdam, Amsterdam, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229919054337406676%22">Journal of human immunity</searchLink> [J Hum Immun] 2026 Apr 09; Vol. 2 (4), pp. e20250240. <i>Date of Electronic Publication: </i>2026 Apr 09 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Rockefeller+University+Press%22">Rockefeller University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9919054337406676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>3065-8993 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2230658993%22">30658993 </searchLink><i>NLM ISO Abbreviation: </i>J Hum Immun <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42169678 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.70962/jhi.20250240 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e20250240 Titles: – TitleFull: Kawasaki disease complicated by macrophage activation syndrome treated with canakinumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Netea SA – PersonEntity: Name: NameFull: van Stijn D – PersonEntity: Name: NameFull: Gruppen MP – PersonEntity: Name: NameFull: van den Berg JM – PersonEntity: Name: NameFull: Blom NA – PersonEntity: Name: NameFull: Kuipers IM – PersonEntity: Name: NameFull: Kuijpers TW IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 04 Text: 2026 Apr 09 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 3065-8993 Numbering: – Type: volume Value: 2 – Type: issue Value: 4 Titles: – TitleFull: Journal of human immunity Type: main |
| ResultId | 1 |